0000905148-18-000758.txt : 20180906
0000905148-18-000758.hdr.sgml : 20180906
20180906142127
ACCESSION NUMBER: 0000905148-18-000758
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180905
FILED AS OF DATE: 20180906
DATE AS OF CHANGE: 20180906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weissman James B
CENTRAL INDEX KEY: 0001598480
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36281
FILM NUMBER: 181057318
MAIL ADDRESS:
STREET 1: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001399529
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617 621 8097
MAIL ADDRESS:
STREET 1: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
4
1
form4.xml
X0306
4
2018-09-05
0001399529
Dicerna Pharmaceuticals Inc
DRNA
0001598480
Weissman James B
C/O DICERNA PHARMACEUTICALS, INC.
87 CAMBRIDGEPARK DRIVE
CAMBRIDGE
MA
02140
true
Chief Business Officer
Common Stock
2018-09-05
4
M
0
2301
3.42
A
26781
D
Common Stock
2018-09-05
4
S
0
2301
17.5
D
24480
D
Employee Stock Option (Right to Buy)
3.42
2018-09-05
4
M
0
2301
0
D
2023-09-24
Common Stock
2301
47699
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 5, 2018.
The vesting of this option is subject to achievement of pre-established performance goals. As of the transaction date, 50% of the option (representing 30,000 shares) was vested.
/s/ James B. Weissman
2018-09-06